Search
forResearch 10 of 1000+
- Eosinophilic folliculitis of the scalp associated with PD‐1/PDL1 inhibitors
- ODP342 Panhypopituitarism Induced by CTLA-4 and PD-1/PD-L1 Inhibitor Immunotherapy
- LB1681 Risk of merkel cell carcinoma progression after treatment discontinuation in patients with an objective response to anti-PD-(L)1 immunotherapy
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Anti-programmed cell death protein 1-induced lichenoid changes of the nail unit: Histopathologic description
- Risk of Autoimmune Skin Diseases Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis Using the FAERS Database
- IMMUNE-RELATED SKIN TOXICITIES TO CHECKPOINT INHIBITORS THERAPY
- 557 A peptide derivative with known anti-wrinkle properties was identified as potent dipeptiylpeptidase-4 inhibitor
- Persistently curly hair phenotype with the use of nivolumab for squamous cell lung cancer
- Recurrent inverse necrotizing infundibular crystalline folliculitis
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →